Bictegravir News

← Back to News Overview


Bictegravir currently has 2 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Bictegravir with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Biktarvy is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or...
  • Evidence level: L5
  • Predicted indications (20):
    • HIV infectious disease (99.9%)
    • simian immunodeficiency virus infection (99.8%)
    • feline acquired immunodeficiency syndrome (99.8%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.8%)
    • AIDS (97.3%)
    • chronic hepatitis C virus infection (95.5%)
    • AIDS related complex (94.8%)
    • congenital human immunodeficiency virus (94.8%)
    • hepatitis C virus infection (93.3%)
    • hepatitis E virus infection (92.1%)
    • hepatitis A virus infection (91.9%)
    • Omsk hemorrhagic fever (91.8%)
    • Kyasanur forest disease (91.7%)
    • hepatitis, viral, animal (91.6%)
    • ulceration of vulva (90.7%)
    • anogenital human papillomavirus infection (90.3%)
    • fibroma of prostate (90.2%)
    • Brenner tumor (90.2%)
    • vulvitis (90.0%)
    • vulvar neoplasm (90.0%)

View full drug report →

Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau - The Guardian

2026-10-09 hepatitis

Source: The Guardian


Meteo estremo, cibo contaminato, ricoveri lunghi. A Roma è boom di Epatite A: perché c’è da preoccuparsi

2026-10-08 epatite

Source: RomaToday


Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.